TipRanks
Fuso Pharmaceutical Industries,Ltd. (JP:4538)
:4538
Japanese Market
4538
Fuso Pharmaceutical Industries,Ltd.
RESEARCH TOOLSreports
Want to see JP:4538 full AI Analyst Report?

Fuso Pharmaceutical Industries,Ltd. (4538) Ratios

0 Followers

Fuso Pharmaceutical Industries,Ltd. Ratios

JP:4538's free cash flow for Q1 2026 was ¥0.26. For the 2026 fiscal year, JP:4538's free cash flow was decreased by ¥ and operating cash flow was ¥0.06. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.12 1.11 1.10 1.52 1.52
Quick Ratio
 0.79 0.81 0.76 1.04 1.08
Cash Ratio
 0.09 0.09 0.14 0.17 0.28
Solvency Ratio
 0.09 0.08 -0.03 0.09 0.10
Operating Cash Flow Ratio
 0.00 -0.12 -0.07 0.02 0.10
Short-Term Operating Cash Flow Coverage
 0.00 -0.23 -0.18 0.11 0.41
Net Current Asset Value
¥ 2.37B¥ 2.07B¥ -1.13B¥ 5.81B¥ 6.40B
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.32 0.26 0.17 0.17
Debt-to-Equity Ratio
 0.74 0.81 0.64 0.35 0.35
Debt-to-Capital Ratio
 0.42 0.45 0.39 0.26 0.26
Long-Term Debt-to-Capital Ratio
 0.05 0.05 0.07 0.16 0.14
Financial Leverage Ratio
 2.45 2.58 2.50 2.07 2.03
Debt Service Coverage Ratio
 0.21 0.18 -0.07 0.65 0.57
Interest Coverage Ratio
 8.33 8.05 25.66 11.49 13.37
Debt to Market Cap
 1.36 1.41 1.02 0.68 0.72
Interest Debt Per Share
 3.12K 3.37K 2.51K 1.50K 1.46K
Net Debt to EBITDA
 3.85 4.39 -5.04 1.81 1.00
Profitability Margins
Gross Profit Margin
25.64%25.67%26.73%24.40%26.94%
EBIT Margin
4.81%4.44%-7.94%3.50%4.65%
EBITDA Margin
8.99%8.64%-4.93%7.58%9.08%
Operating Profit Margin
4.80%4.24%6.82%3.55%4.32%
Pretax Profit Margin
4.30%3.91%-8.21%3.19%4.32%
Net Profit Margin
3.49%3.23%-5.43%2.49%3.15%
Continuous Operations Profit Margin
3.49%3.23%-5.43%2.49%3.15%
Net Income Per EBT
81.09%82.49%66.16%77.93%72.79%
EBT Per EBIT
89.59%92.35%-120.28%89.92%99.95%
Return on Assets (ROA)
2.50%2.23%-3.98%1.82%2.21%
Return on Equity (ROE)
6.28%5.74%-9.95%3.76%4.50%
Return on Capital Employed (ROCE)
7.68%6.83%10.76%4.26%5.01%
Return on Invested Capital (ROIC)
3.84%3.34%4.78%2.96%3.16%
Return on Tangible Assets
2.54%2.26%-4.06%1.83%2.22%
Earnings Yield
11.33%9.97%-15.76%7.39%9.17%
Efficiency Ratios
Receivables Turnover
 2.65 2.32 2.29 2.28 2.35
Payables Turnover
 7.45 6.54 5.14 2.55 2.54
Inventory Turnover
 2.95 2.95 2.97 2.95 2.99
Fixed Asset Turnover
 2.83 2.81 2.62 2.27 2.15
Asset Turnover
 0.72 0.69 0.73 0.73 0.70
Working Capital Turnover Ratio
 10.87 12.63 6.21 3.69 3.62
Cash Conversion Cycle
 212.33 225.37 211.59 140.89 133.72
Days of Sales Outstanding
 137.63 157.57 159.66 160.27 155.55
Days of Inventory Outstanding
 123.67 123.59 122.90 123.75 121.91
Days of Payables Outstanding
 48.97 55.79 70.97 143.13 143.74
Operating Cycle
 261.30 281.16 282.56 284.02 277.47
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 -728.92 -386.87 72.82 325.27
Free Cash Flow Per Share
 0.00 -877.19 -635.26 -343.88 145.82
CapEx Per Share
 0.00 148.27 248.39 416.70 179.45
Free Cash Flow to Operating Cash Flow
 0.00 1.20 1.64 -4.72 0.45
Dividend Paid and CapEx Coverage Ratio
 0.00 -3.11 -1.20 0.15 1.36
Capital Expenditure Coverage Ratio
 0.00 -4.92 -1.56 0.17 1.81
Operating Cash Flow Coverage Ratio
 0.00 -0.22 -0.16 0.05 0.23
Operating Cash Flow to Sales Ratio
 0.00 -0.10 -0.05 0.01 0.06
Free Cash Flow Yield
0.00%-37.12%-26.01%-15.89%7.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 8.83 10.03 -6.34 13.53 10.91
Price-to-Sales (P/S) Ratio
 0.31 0.32 0.34 0.34 0.34
Price-to-Book (P/B) Ratio
 0.54 0.58 0.63 0.51 0.49
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -2.69 -3.84 -6.29 13.69
Price-to-Operating Cash Flow Ratio
 0.00 -3.24 -6.31 29.72 6.14
Price-to-Earnings Growth (PEG) Ratio
 0.07 -0.06 0.02 -1.07 1.32
Price-to-Fair Value
 0.54 0.58 0.63 0.51 0.49
Enterprise Value Multiple
 7.27 8.13 -12.03 6.25 4.78
Enterprise Value
 41.07B 43.79B 35.89B 26.24B 22.13B
EV to EBITDA
 7.27 8.13 -12.03 6.25 4.78
EV to Sales
 0.65 0.70 0.59 0.47 0.43
EV to Free Cash Flow
 0.00 -5.85 -6.61 -8.86 17.30
EV to Operating Cash Flow
 0.00 -7.04 -10.86 41.84 7.76
Tangible Book Value Per Share
 4.04K 3.95K 3.69K 4.19K 4.03K
Shareholders’ Equity Per Share
 4.19K 4.11K 3.87K 4.26K 4.06K
Tax and Other Ratios
Effective Tax Rate
 0.19 0.17 0.34 0.22 0.27
Revenue Per Share
 7.36K 7.30K 7.09K 6.43K 5.82K
Net Income Per Share
 256.66 235.52 -384.88 159.92 182.99
Tax Burden
 0.81 0.82 0.66 0.78 0.73
Interest Burden
 0.89 0.88 1.03 0.91 0.93
Research & Development to Revenue
 0.00 0.00 0.03 0.03 0.03
SG&A to Revenue
 0.21 0.21 0.17 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 -3.09 1.01 0.35 1.29
Currency in JPY